Non-Hodgkin lymphoma: Difference between revisions
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{CMG}};{{AE}} {{Preeti | {{CMG}};{{AE}} {{Preeti}} | ||
{{SK}} NHL; Non-Hodgkin's disease; B-cell NHLs; T-cell and NK–cell NHLs | {{SK}} NHL; Non-Hodgkin's disease; B-cell NHLs; T-cell and NK–cell NHLs | ||
| Line 41: | Line 41: | ||
[[Non-Hodgkin lymphoma case study one|Case #1]] | [[Non-Hodgkin lymphoma case study one|Case #1]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
Revision as of 23:51, 19 January 2019
| Non-Hodgkin's Lymphoma | |
 | |
|---|---|
| Malignant lymphoma, high grade B cell, not otherwise specified (Courtesy of Ed Uthman, MD) |
|
Non-Hodgkin lymphoma Microchapters |
|
Differentiating Non-Hodgkin's Lymphoma |
|---|
|
Treatment |
|
Case Studies |
|
Non-Hodgkin lymphoma On the Web |
|
American Roentgen Ray Society Images of Non-Hodgkin lymphoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Synonyms and keywords: NHL; Non-Hodgkin's disease; B-cell NHLs; T-cell and NK–cell NHLs
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Non-Hodgkin lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice | Staging | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Ultrasound | Biopsy | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies